Products
3777 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
| Code | Description | Unit |
|---|---|---|
| 1478221 | Oligosaccharide System Suitability Mixture B (20 ug) | 20 ug |
| 1478232 | Oligosaccharide System Suitability Mixture C (20 ug) | |
| 1478243 | Oligosaccharide System Suitability Mixture D (20 ug) | |
| 1478265 | Olive Leaf Dry Extract (500 mg) | 500 mg |
| 1478254 | Olive Oil (5 x 200 mg) | 1000 mg |
| 1478367 | Olmesartan Medoxomil (100 mg) | 100 mg |
| 1478378 | Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) | 20 mg |
| 1478403 | Olopatadine Hydrochloride (150 mg) | 150 mg |
| 1478425 | Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide) | 35 mg |
| 1478436 | Olopatadine Related Compound C (35 mg) ((11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid) | 35 mg |
| 1478505 | Omeprazole (200 mg) | 200 mg |
| 1478549 | Omeprazole Magnesium (10 mg) | 10 mg |
| 1478516 | Omeprazole Related Compound A (15 mg) (5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole) | 15 mg |
| 1478480 | Omeprazole Related Compound B (15 mg) (5-Methoxy-1H-benzimidazol-2-thiol) | 15 mg |
| 1478527 | Omeprazole Related Compound E (15 mg) (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide) | 15 mg |
| 1478491 | Omeprazole Related Compound F and G Mixture (25 mg) | 25 mg |
| 1478561 | Omeprazole Related Compound I (15 mg) (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) | 15 mg |
| 1478571 | Ondansetron (300 mg) | 300 mg |
| 1478582 | Ondansetron Hydrochloride (300 mg) | 300 mg |
| 1478593 | Ondansetron Related Compound A (50 mg) (3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride) | 50 mg |
| 1478618 | Ondansetron Related Compound C (30 mg) (1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one) | 30 mg |
| 1478629 | Ondansetron Related Compound D (30 mg) (9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one) | 30 mg |
| 1478630 | Ondansetron Resolution Mixture (50 mg) | 50 mg |
| 1478651 | Ononin (50 mg) (3-(4-Methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) | 50 mg |
| 1046409 | Open Ring Aztreonam (10 mg) | 10 mg |
| 1478673 | Orbifloxacin (350 mg) | 350 mg |
| 1478800 | Orlistat (200 mg) (COLD SHIPMENT REQUIRED) | 200 mg |
| 1478811 | Orlistat Related Compound A (25 mg) ((3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone) | 25 mg |
| 1478822 | Orlistat Related Compound B (20 mg) (diisopropyl hydrazine-1,2-dicarboxylate) | 20 mg |
| 1478833 | Orlistat Related Compound C (25 mg) (Triphenylphosphine oxide) | 25 mg |
| 1478844 | Orlistat Related Compound D (10 mg) (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) | 10 mg |
| 1478855 | Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) | 10 mg |
| 1479009 | Orphenadrine Citrate (200 mg) | 200 mg |
| 1479010 | Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) | 50 mg |
| 1479020 | Orphenadrine Related Compound B (20 mg) (N-ethyl-N,N-dimethyl [2-(2-methylbenzhydryloxy)ethyl]ammonium chloride) | 20 mg |
| 1479031 | Orphenadrine Related Compound C (20 mg) (N-methyl-[2-(2-methylbenzhydryloxy)ethyl]amine hydrochloride) | 20 mg |
| 1479053 | Orphenadrine Related Compound E (50 mg) (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) | 50 mg |
| 1479064 | Orphenadrine Related Compound F (50 mg) (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) | 50 mg |
| 1479304 | Oseltamivir Phosphate (200 mg) | 200 mg |
| 1479315 | Oseltamivir Related Compound A (10 mg) ((3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate) | 10 mg |
| 1133580 | Oversulfated Chondroitin Sulfate (10 mg) | 10 mg |
| 1481044 | Oxacillin Related Compound C (15 mg) (5-Methyl-3-phenylisoxazole-4-carboxylic acid) | 15 mg |
| 1481000 | Oxacillin Sodium (200 mg) | 200 mg |
| 1481204 | Oxaliplatin (125 mg) | 125 mg |
| 1481215 | Oxaliplatin Related Compound A (100 mg) (Ethanedioic acid, dihydrate) | 100 mg |
| 1481226 | Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II)) | 15 mg |
| 1481237 | Oxaliplatin Related Compound C (20 mg) ([1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum(IV)) | 20 mg |
| 1481248 | Oxaliplatin Related Compound D (10 mg) (cis-[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum) | 10 mg |
| 1481260 | Oxaliplatin Related Compound F (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II)) | 25 mg |
| 1481306 | Oxaliplatin System Suitability (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dichloridoplatinum(II)) | 25 mg |
| 1482003 | Oxandrolone CIII (50 mg) | 50 mg |
| 1482014 | Oxandrolone Related Compound A CIII (20 mg) (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) | 20 mg |
| 1482025 | Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) | 20 mg |
| 1482036 | Oxandrolone Related Compound C CIII (20 mg) (17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one) | 20 mg |
| 1482207 | Oxaprozin (200 mg) | 200 mg |
| 1483006 | Oxazepam CIV (200 mg) | 200 mg |
| 1483017 | Oxazepam Related Compound A (15 mg) (7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) | 15 mg |
| 1483028 | Oxazepam Related Compound B (15 mg) (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate) | 15 mg |
| 1483039 | Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) | 15 mg |
| 1483152 | Oxcarbazepine (100 mg) | 100 mg |
| 1483163 | Oxcarbazepine Related Compound A (10 mg) (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | 10 mg |
| 1483174 | Oxcarbazepine Related Compound B (10 mg) (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | 10 mg |
| 1483185 | Oxcarbazepine Related Compound C (10 mg) (Acridin-9(10H)-one) | 10 mg |
| 1483196 | Oxcarbazepine Related Compound D (10 mg) (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide) | 10 mg |
| 1483200 | Oxcarbazepine Related Compound E (10 mg) (10(11H)-Oxo-5H-dibenz[b,f]azepine) | 10 mg |
| 1483301 | Oxfendazole (200 mg) | 200 mg |
| 1483425 | Oxiconazole Nitrate (200 mg) | 200 mg |
| 1483436 | Oxiconazole Related Compound A (20 mg) (2',4'-Dichloro-2-imidazol-1-ylacetophenone (E)-[O-(2,4-dichlorobenzyl)oxime]) | 20 mg |
| 1483447 | Oxiconazole Related Compound B (20 mg) ((Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime) | 20 mg |
| 1483458 | Oxiconazole Related Compound C (20 mg) (1-(2,4-Dichlorophenyl)-2-(1H -imidazol-1-yl)ethan-1-one hydrochloride) | 20 mg |
| 1483469 | Oxiconazole Related Compound D (50 mg) ((2,4-Dichlorophenyl)methanol) | 50 mg |
| 1483470 | Oxiconazole Related Compound E (100 mg) (2,4-Dichlorobenzyl chloride) | 100 mg |
| 1483505 | Oxprenolol Hydrochloride (200 mg) | 200 mg |
| 1484009 | Oxtriphylline (500 mg) | 500 mg |
| 1485001 | Oxybenzone (150 mg) | 150 mg |
| 1485103 | Oxybutynin Chloride (200 mg) | 200 mg |
| 1485114 | Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) | 100 mg |
| 1485125 | Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) | 20 mg |
| 1485136 | Oxybutynin Related Compound C (20 mg) (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride) | 20 mg |
| 1485191 | Oxycodone CII (200 mg) | 200 mg |
| 1485205 | Oxycodone Hydrochloride CII (1 g) | 1 g |
| 1485216 | Oxycodone Related Compound A CII (10 mg) (14-hydroxycodeinone) (COLD SHIPMENT REQUIRED) | 10 mg |
| 1485227 | Oxycodone Related Compound B CII (15 mg) (oxycodone N-oxide) | 15 mg |
| 1485238 | Oxycodone Related Compound C CII (15 mg) (codeinone) | 15 mg |
| 1486004 | Oxymetazoline Hydrochloride (200 mg) | 200 mg |
| 1486015 | Oxymetazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) | 15 mg |
| 1487007 | Oxymetholone CIII (200 mg) | 200 mg |
| 1488000 | Oxymorphone CII (300 mg) | 300 mg |
| 1488019 | Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) | 25 mg |
| 1490103 | Oxyquinoline Sulfate (200 mg) | 200 mg |
| 1491004 | Oxytetracycline (200 mg) | 200 mg |
| 1491015 | Oxytetracycline Hydrochloride (200 mg) | 200 mg |
| 1491300 | Oxytocin (1.81 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 1.81 mg |
| 1491296 | Oxytocin Identification (15 mg) (COLD SHIPMENT REQUIRED) | 15 mg |
| 1111908 | P-Chloroaniline (200 mg) | 200 mg |
| 1467837 | PS NMR System Suitability (1 mg) | 1 mg |
| 1491332 | Paclitaxel (200 mg) | 200 mg |
| 1491365 | Paclitaxel Impurity Mixture (10 mg) | 10 mg |
| 1491343 | Paclitaxel Related Compound A (20 mg) (Cephalomannine) | 20 mg |
| 1491354 | Paclitaxel Related Compound B (20 mg) (10-deacetyl-7-epipaclitaxel) | 20 mg |